COVID-19 vaccines: authorised
4 November 2022 – The European Commission authorised the conversion of the conditional marketing authorisation for Vaxzevria to standard marketing authorization.
For more information, see here.
4 November 2022 – The European Commission authorised the conversion of the conditional marketing authorisation for Vaxzevria to standard marketing authorization.
For more information, see here.